4Stoupakis G, Klaphotz M. Natriuretic peptides: biochemistry, physiolo- gy, and therapeutic role in heart failure [J] . Heart Dis, 2003, 5 (2) :215-223.
5Yeo KT, Wu AH, Apple FS, et al. Muhicenter evaluation of e roche NT-pmBNP assay and comparison to the biosite triage BNP assay [J] . Clinica Chimica Acta, 2003, 338:107-115.
6Stoupakis G, Klapholz M. Natriuretic peptides: biochemistry, physiolo- gy, and therapeutic role in heart failure [J] . Heart Dis, 2003, 5 (2) : 215-223.
7Clerio A, Lervasi G, Ckicca M, et al. Circulating levels of carolae na- trluretuc peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure [J] . Endocrinol Invest, 1998, 21: 170-179.
8Fang J, Aldeman MH, Femen H. Serum uric acid and cardiovascular mortality the NHANES 1 epidemiologic follow-up study, 1971-1992 [J] . JAMA, 2000, 283 (18) : 2404-2410.
9Pascuai-Figal DA, Hurtado-Martinez JA, Redondo B, et al. Hyperuri- caemia and long-term outcome after hospital discharge in acute heart failure patients [ J]. Ear J Heart Fail,2007,9:437-439.
10Sakai H,Ts utamoto T, Tsutsui T, et al. Serum level of uric acid, partly secreted form the failing heart is a prognostic marker in pa- tients with congestive heart failure [ J ]. Circ J, 2006,70 : 1006-1011.
